Logo image
Extended sequence preferences for oligodeoxyribonucleotide activity
Journal article   Open access   Peer reviewed

Extended sequence preferences for oligodeoxyribonucleotide activity

Petar Lenert, Adam J Goeken and Robert F Ashman
Immunology, Vol.117(4), pp.474-481
04/2006
DOI: 10.1111/j.1365-2567.2006.02320.x
PMCID: PMC1782261
PMID: 16556261
url
https://doi.org/10.1111/j.1365-2567.2006.02320.xView
Published (Version of record) Open Access

Abstract

Synthetic type B phosphorothioate oligodeoxyribonucleotides (ODN) activate mouse B cells via Toll-like receptor 9 (TLR9). Starting with closely related 15-mer prototype ODN, the sequence requirements for stimulatory (ST-) and inhibitory (IN-) activity were contrasted, by measuring apoptosis protection, G(1) entry and interleukin-6 secretion. ST-ODN and IN-ODN differ in that (1) ST-ODN require a 5' T, (2) the central CG is obligatory, (3) CG must be flanked 3' specifically by TT at the position where IN-ODN have GG, and (4) IN-ODN tolerate truncation of the 3' end better than ST-ODN. Features shared by ST-ODN and IN-ODN include (1) requiring CC adjacent to the 5' end, and (2) avoiding CC immediately 5' to the CG. This pattern is used to create a model of how ST-ODN binding might function to aggregate TLR9 so as to initiate the signal, and how the 5' ends of ST-ODN and IN-ODN compete for binding. Further justification for considering TLR9 to be the ODN receptor was provided by a demonstration that in HEK293 cells transfected with TLR9, the potency of a panel of ODN for activating NF-kappaB roughly parallels that seen in the biological assays in mouse B cells.
G1 Phase - immunology CpG Islands - immunology DNA-Binding Proteins - immunology Dose-Response Relationship, Immunologic Oligodeoxyribonucleotides - immunology Cells, Cultured NF-kappa B - metabolism Structure-Activity Relationship Mice, Inbred Strains Toll-Like Receptor 9 - immunology Animals Apoptosis - immunology B-Lymphocytes - immunology Oligodeoxyribonucleotides - genetics Base Sequence Female Mice Interleukin-6 - metabolism

Details

Metrics

Logo image